From: The frequency and availability of population-specific patient reported outcome measures and minimal clinically important differences among approved drugs in Canada
PROM validated in study population
Disease specific n (%)
Generic n (%)
Total n (%)
Not validated
11 (18)
24 (56)
35
Validateda
47 (76)
15 (35)
62
No reference given
4 (6)
4 (9)
8
Total
43
105 (p = < 0.001)